BE859912A - Nouveaux derives de psoralene - Google Patents

Nouveaux derives de psoralene

Info

Publication number
BE859912A
BE859912A BE181894A BE181894A BE859912A BE 859912 A BE859912 A BE 859912A BE 181894 A BE181894 A BE 181894A BE 181894 A BE181894 A BE 181894A BE 859912 A BE859912 A BE 859912A
Authority
BE
Belgium
Prior art keywords
psoralene
new derivatives
derivatives
new
Prior art date
Application number
BE181894A
Other languages
English (en)
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of BE859912A publication Critical patent/BE859912A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
BE181894A 1976-10-20 1977-10-19 Nouveaux derives de psoralene BE859912A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/734,031 US4124598A (en) 1976-10-20 1976-10-20 Psoralens

Publications (1)

Publication Number Publication Date
BE859912A true BE859912A (fr) 1978-04-19

Family

ID=24950058

Family Applications (1)

Application Number Title Priority Date Filing Date
BE181894A BE859912A (fr) 1976-10-20 1977-10-19 Nouveaux derives de psoralene

Country Status (9)

Country Link
US (1) US4124598A (fr)
JP (2) JPS5353699A (fr)
BE (1) BE859912A (fr)
CH (1) CH635346A5 (fr)
DE (1) DE2746942A1 (fr)
FR (1) FR2376859A1 (fr)
GB (1) GB1556307A (fr)
IT (1) IT1087022B (fr)
NL (1) NL7711539A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169204A (en) * 1976-10-20 1979-09-25 Regents Of The University Of California Psoralens
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269851A (en) * 1979-09-10 1981-05-26 Thomas C. Elder, Inc. 8-Aminoalkyl-4-alkylpsoralens
US4328239A (en) * 1979-09-10 1982-05-04 Elder Pharmaceuticals, Inc. 8-Aminoalkylpsoralens
US4269852A (en) * 1979-09-10 1981-05-26 Thomas C. Elder, Inc. 4'-Substituted-4,5',8-trialkylpsoralens
US4370344A (en) * 1979-09-10 1983-01-25 Elder Pharmaceuticals, Inc. 5'-Aminoalkyl-4'-alkylpsoralens
US4298614A (en) * 1979-09-10 1981-11-03 Thomas C. Elder, Inc. 5'-Aminoalkyl-4',4-dialkylpsoralens
US4398031A (en) * 1980-06-11 1983-08-09 The Regents Of The University Of California Coumarin derivatives and method for synthesizing 5'-methyl psoralens therefrom
US4279922A (en) * 1980-07-29 1981-07-21 Thomas C. Elder, Inc. Photosensitizing benzofuranacrylics
US4294822A (en) * 1980-07-29 1981-10-13 Thomas C. Elder, Inc. 5-Aminoalkyl-4,4,8-trialkylpsoralens
US5176921A (en) * 1983-05-02 1993-01-05 Diamond Scientific Co. Method of blood component decontamination by glucose addition
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4959309A (en) * 1983-07-14 1990-09-25 Molecular Diagnostics, Inc. Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays
US4693981A (en) * 1983-12-20 1987-09-15 Advanced Genetics Research Institute Preparation of inactivated viral vaccines
US4556556A (en) * 1984-03-23 1985-12-03 Advanced Genetics Research Institute Vaccine for the prevention of vesicular stomatitis virus infection
US4751313A (en) * 1984-03-21 1988-06-14 Cetus Corporation Precursor to nucleic acid probe
US4582789A (en) * 1984-03-21 1986-04-15 Cetus Corporation Process for labeling nucleic acids using psoralen derivatives
US4705886A (en) * 1984-03-21 1987-11-10 Cetus Corporation Precursor to nucleic acid probe
US4803297A (en) * 1984-03-21 1989-02-07 Cetus Corporation Carbamic acid ester useful for preparing a nucleic acid probe
US4617261A (en) * 1984-03-21 1986-10-14 Cetus Corporation Process for labeling nucleic acids and hybridization probes
US4754065A (en) * 1984-12-18 1988-06-28 Cetus Corporation Precursor to nucleic acid probe
US4822731A (en) * 1986-01-09 1989-04-18 Cetus Corporation Process for labeling single-stranded nucleic acids and hybridizaiton probes
US4950770A (en) * 1987-06-16 1990-08-21 Elder Pharmaceuticals, Inc. Psoralens aminomethylation
WO1990001563A1 (fr) * 1988-08-01 1990-02-22 Cimino George D Identification de sequences d'acide nucleique specifiques d'alleles par hybridation au moyen de sondes d'oligonucleotides reticulables
US5356929A (en) * 1989-01-23 1994-10-18 Lehigh University Reduced and quaternized psoralens as photo-activated therapeutics
US5532146A (en) * 1989-10-26 1996-07-02 Hri Research, Inc. Method for rendering ligase-based amplification products unamplifiable
US5556958A (en) * 1989-10-26 1996-09-17 Steritech, Inc. Inactivation of pathogens in clinical samples
AU649992B2 (en) * 1989-10-26 1994-06-09 George D. Cimino Activation compounds and methods for nucleic acid sterilization
US5139940A (en) * 1989-10-26 1992-08-18 Isaacs Stephen T Activation compounds and methods of synthesis of activation compounds
US5503721A (en) 1991-07-18 1996-04-02 Hri Research, Inc. Method for photoactivation
US5532145A (en) * 1989-10-26 1996-07-02 Steritech, Inc. Methods for treatment of enzyme preparations
US5798238A (en) * 1990-04-16 1998-08-25 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer
JP2538105Y2 (ja) * 1990-11-27 1997-06-11 松下電工株式会社 立体ガレージ
US5372929A (en) * 1992-01-27 1994-12-13 Cimino; George D. Methods for measuring the inactivation of pathogens
US6433343B1 (en) 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
US5618662A (en) * 1992-03-02 1997-04-08 Cerus Corporation Intravenous administration of psoralen
US5709991A (en) * 1992-03-02 1998-01-20 Cerus Corporation Proralen inactivation of microorganisms and psoralen removal
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5459030A (en) * 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
WO1996014740A1 (fr) 1992-03-02 1996-05-23 Cerus Corporation Produits synthetiques pour preparations sanguines
JPH08504174A (ja) * 1992-08-07 1996-05-07 ステリテック，インコーポレーテッド ８−メトキシプソラレンによる血液製剤中のバクテリアの失活方法
US5593823A (en) * 1993-06-28 1997-01-14 Cerus Corporation Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US6004741A (en) * 1993-06-28 1999-12-21 Cerus Corporation Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens in platelet preparations
US6004742A (en) * 1993-06-28 1999-12-21 Cerus Corporation Method for inactivation of pathogens in platelets using 4' and 5' primary amino-substituted psoralens
US6420570B1 (en) 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US5556993A (en) 1993-06-28 1996-09-17 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US5871900A (en) * 1993-06-28 1999-02-16 Cerus Corporation Method of inactivating pathogens in biological fluids using photoactivated 5-primaryamino psoralens
US5691132A (en) * 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
US6177441B1 (en) 1995-06-05 2001-01-23 Cerus Corporation Treating red blood cell solutions with anti-viral agents
US20020115585A1 (en) * 1996-06-07 2002-08-22 Hei Derek J. Method and devices for the removal of psoralens from blood products
US5780446A (en) * 1996-07-09 1998-07-14 Baylor College Of Medicine Formulations of vesicant drugs and methods of use thereof
AU747842B2 (en) 1997-11-20 2002-05-23 Cerus Corporation New psoralens for pathogen inactivation
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US6277337B1 (en) 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6255324B1 (en) 1998-11-25 2001-07-03 Ned D. Heindel Amino-and mercurio-substituted 4′,5'-dihydropsoralens and therapeutical uses thereof
EP1144417B1 (fr) 1998-11-30 2002-09-04 Buckman Laboratories International, Inc. Dihydropsoralenes-4', 5' substitues en position 4 et leurs utilisations therapeutiques
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
FR2803849B1 (fr) * 2000-01-19 2002-04-19 Centre Nat Rech Scient Molecules chimeres formees de psoralene et de retinoide, leur procede de preparation, et leurs applications au traitement de pathologies de l'hyperproliferation cellulaire et notamment du psoriasis
US20020015937A1 (en) * 2000-01-31 2002-02-07 Setcavage Thomas M. Methods for inactivating viruses
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
GB0710846D0 (en) * 2007-06-06 2007-07-18 Bristol Myers Squibb Co A wound dressing
US8071642B2 (en) * 2007-06-28 2011-12-06 Rutgers, The State University Of New Jersey Dimethyl amino ethyl ether psoralens and methods for their production and use
US8835104B2 (en) 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
US9005633B2 (en) * 2009-07-17 2015-04-14 The United States Of America As Represented By The Secretary Of The Navy. Psoralen-inactivated viral vaccine and method of preparation
ES2656498T3 (es) * 2010-09-07 2018-02-27 Sigma-Aldrich Co. Llc Células para inmunoprecipitación de cromatina y procedimiento de fabricación de las mismas
JP2014518547A (ja) 2011-04-07 2014-07-31 フェンウォール、インコーポレイテッド 削減された残存血漿容積を有する血小板濃縮物を提供するための自動化方法とシステムおよびそのような血小板濃縮物のための貯蔵媒体
WO2014030066A2 (fr) 2012-08-22 2014-02-27 Bernitz Mats Nilsson Procédés pour identifier des séquences d'acide nucléique
US20140127077A1 (en) 2012-11-05 2014-05-08 Gail Rock Device and method for sterilization of instruments and surfaces

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3201421A (en) * 1962-05-09 1965-08-17 Dept Of Chemistry Preparation of alkyl psoralens

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169204A (en) * 1976-10-20 1979-09-25 Regents Of The University Of California Psoralens
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants

Also Published As

Publication number Publication date
JPS62153B2 (fr) 1987-01-06
FR2376859B1 (fr) 1981-02-27
GB1556307A (en) 1979-11-21
DE2746942A1 (de) 1978-04-27
FR2376859A1 (fr) 1978-08-04
DE2746942C2 (fr) 1988-05-26
JPS6326119B2 (fr) 1988-05-27
CH635346A5 (de) 1983-03-31
NL7711539A (nl) 1978-04-24
JPS6212795A (ja) 1987-01-21
US4124598A (en) 1978-11-07
JPS5353699A (en) 1978-05-16
IT1087022B (it) 1985-05-31

Similar Documents

Publication Publication Date Title
BE859912A (fr) Nouveaux derives de psoralene
BE852060A (fr) Derives polyoxygenes du labdane
BE851122A (fr) Nouveaux derives de prostaglandine
BE868532A (fr) Nouveaux derives de la thiazolidine
FR2342736A1 (fr) Nouveaux derives de diazepine
BE852141A (fr) Nouveaux derives de sulfonamide
FR2348926A1 (fr) Nouveaux derives de l'adenine
FR2298332A1 (fr) Nouveaux derives de 5-fluorouraciles
FR2316926A1 (fr) Nouveaux derives de bicycloheptenes
BE852941A (fr) Nouveaux derives de prostaglandine
FR2301253A1 (fr) Derives de la
BE850492A (fr) Nouveaux derives de la piperazine
BE853578A (fr) Derives de thiouree
BE851443A (fr) Nouveaux derives de la piperazine
BE859439A (fr) Nouveaux derives de piperazine
BE859567A (fr) Derives piperidylideniques de benzo-xanthenes
BE852143A (fr) Nouveaux derives du cholesterol
BE854249A (fr) Nouveaux derives des benzodiazepines
BE866933A (fr) Nouveaux derives de fortmicine
FR2338701A1 (fr) Nouveaux derives de la cysteine
BE850089A (fr) Nouveaux derives de l'hydrazine
BE857639A (fr) Nouveaux derives de 5-thiazole alkylamine
BE852457A (fr) Nouveaux derives 17-spirosultines
BE861968A (fr) Nouveaux derives acyle de hellebrigenine
FR2351084A1 (fr) Nouveaux derives naphtyliques

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Effective date: 19911031